- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Low Leverage High Rewards
Hong Kong Pharmaceuticals & Biotech Low Leverage High Rewards
Results
5
5 companies
Essex Bio-Technology
Market Cap: HK$1.9b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$3.29
7D
-2.7%
1Y
-28.2%
Shandong Xinhua Pharmaceutical
Market Cap: HK$9.6b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$6.34
7D
-0.9%
1Y
13.2%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$6.4b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$7.62
7D
-0.5%
1Y
-13.0%
Tong Ren Tang Technologies
Market Cap: HK$5.0b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$3.94
7D
0.5%
1Y
-18.3%
Jacobson Pharma
Market Cap: HK$2.3b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.14
7D
-5.0%
1Y
-6.6%